What is Farioscapulohumeral muscle dystrophy?

Farioscapulohumeral muscle dystrophy (FSHMD) is a muscle state that causes progressive loss of muscle function. FSHMD is also known as the muscle dystrophy of Landouzy-Dejerine, a neuromuscular disorder that initially represents itself as a deteriorated central muscle function for the upper body, including shoulders and arms. There is no medicine for FSHMD. As a result of the gradual progression of the disease, treatment generally concerns the use of physical therapy and drugs that help prolong the ability of a person to remain mobile.

considered autosomal dominant disorder, Farioscapulohumeral muscle dystrophy is caused by the presence of a dominant protein mutation carried by autosome or nonsex chromosome. The passage of the mutated protein gene of dystrophin depends on the fact that one parent is a carrier. A child inherited by a mutated gene has a chance of 50/50 for the development of farioscapumeral muscle dystrophy or related myotonic disorders.

In most cases, the Plays family history is a key role in the Fari diagnosticsOscapulohumeral muscle dystrophy. After extensive consultation and physical examination, a number of diagnostic tests are generally ordered to confirm the diagnosis. Blood tests are performed to detect the presence of specific enzymes associated with inflammation and muscle worsening, as it occurs in muscle dystrophy (MD). To determine the presence of markers testifying to MD and evaluating any abnormalities in the electrical activity of their muscles and evaluating any abnormalities in the electrical activity of muscles muscles and electromyography.

symptoms associated with this form of MD generally present in adolescence. Individuals often show poor muscle face control, such as the inability to blink, close your eyes or move lips. Progressive muscle atrophy initially affects the upper torso and over time descends to influence the hips. Finally, the muscles in the lower limbs begin atrophy and threaten mobility. Although PRThe symptoms can be patterned, its severity may vary depending on the level of disease progression.

In the absence of treatment for Farioscapulohumeral muscle dystrophy, treatment is focused on prolonging human mobility. Medicines such as corticosteroids are used to control and prevent muscle cramps, known as myotonia and worsening. Individuals can be equipped with braces that offer support and promote flexibility in the limbs.

Physical therapy is the cornerstone of almost all MD therapies and is used to avert the effects of muscle weakness and worsening of the joints. As the muscles shorten and lose their flexibility, the process known as contracture is the ability to move seriously. The aim of physical therapy is to educate the extent of movement and flexibility of joints in an effort to delay the onset of the contract. Individuals who develop serious foods can undergo surgery known as surgery of tendon release to alleviate discomfort in areas like FriTera, hips and lower limbs.